摘要
目的探讨剖宫产后阴道试产(TOLAC)的安全性及可行性。方法选取2015年6月至2017年5月收治的37例TOLAC产妇作为实验组,另选取同期58例选择性再次剖宫产(ERCS)产妇作为对照组。比较两组产妇的分娩结局、母婴结局、住院时间和住院费用。结果剖宫产后阴道分娩(VBAC)率为86.5%。VBAC组的24 h出血量、住院时间、住院费用均明显少于对照组(P<0.05)。VBAC组与对照组的新生儿出生1 min Apgar评分、新生儿入住NICU率比较差异均无统计学意义(P>0.05)。结论与ERCS组相比,VBAC组24小时产后出血量少、住院时间短、住院费用低。因此符合阴道试产条件的TOLAC具有一定的安全性及可行性。
Objective To investigate the safety and feasibility of vaginal trial of labor after cesarean section （TOLAC）. Methods 37 cases of TOLAC puerperas from June 2015 to May 2017 were selected as experimental group. Another 58 cases of puerperas with elective repeat cesarean section （ERCS） at the same period were selected as control group. The pregnancy outcome, maternal and infant outcome, hospitalization stay and hospitalization expense were compared between the two groups. Results The rate of vaginal birth after cesarean （VBAC） was 86.5%. 24 h blood loss, hospitalization time, hospitalization expense in VBAC group was significantly less than that in control group （P 〈0.05）. No statistical difference was found in neonatal 1 min Apgar score and neonatal NICU rate between the two groups （P〉0.05）. Conclusions Compared with ERCS group, VBAC group has less 24 hour postpartum blood loss, shorter hospitalization stay and lower hospitalization expense. So TOLAC has certain feasibility and safety, as it meets the requirements of vaginal trial labor.
出处
《临床医学工程》
2017年第11期1589-1590,共2页
Clinical Medicine & Engineering
关键词
剖宫产后阴道试产
剖宫产后阴道分娩
瘢痕子宫
Trial of labor after cesarean
Vaginal birth after cesarean
Scarred uterus
